Conestoga Capital Advisors Boosts LeMaitre Vascular Stake to 9.6%

TL;DR

**Conestoga Capital Advisors now owns 9.6% of LeMaitre Vascular, showing continued strong institutional interest.**

AI Summary

Conestoga Capital Advisors, LLC, a Delaware-based investment advisor, filed an amended SC 13G/A on January 5, 2024, disclosing its ownership in LeMaitre Vascular, Inc. As of December 31, 2023, Conestoga beneficially owned 2,061,262 shares of LeMaitre Vascular's Common Stock, representing 9.6% of the company. This is an update to their previous filing, showing a slight decrease in their sole voting power to 1,927,971 shares, but an increase in overall beneficial ownership, indicating their continued significant, albeit passive, interest in the medical device company.

Why It Matters

This filing shows a major institutional investor, Conestoga Capital Advisors, maintains a significant stake in LeMaitre Vascular, signaling their continued confidence in the company's long-term prospects. For investors, this indicates that a professional money manager sees value in the stock, which can be a positive sign.

Risk Assessment

Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate risks or significant changes in company control.

Analyst Insight

A smart investor would note the continued strong institutional ownership by Conestoga Capital Advisors, LLC, which could signal underlying confidence in LeMaitre Vascular's business. This might prompt further research into LeMaitre Vascular's fundamentals and future growth prospects, especially given the passive nature of the investment.

Key Numbers

• 2,061,262 — Total Shares Beneficially Owned (This is the total number of LeMaitre Vascular shares Conestoga Capital Advisors, LLC beneficially owns as of December 31, 2023.)
• 9.6% — Percentage of Class Owned (This represents the percentage of LeMaitre Vascular's Common Stock owned by Conestoga Capital Advisors, LLC.)
• 1,927,971 — Sole Voting Power Shares (This is the number of shares over which Conestoga Capital Advisors, LLC has sole voting power.)
• 0 — Shared Voting Power Shares (Conestoga Capital Advisors, LLC has no shared voting power over LeMaitre Vascular shares.)
• 2,061,262 — Sole Dispositive Power Shares (This is the number of shares over which Conestoga Capital Advisors, LLC has sole dispositive power.)

Key Players & Entities

• Conestoga Capital Advisors, LLC (company) — the reporting person and institutional investor
• LeMaitre Vascular, Inc. (company) — the subject company whose shares are being reported
• Delaware (company) — state of incorporation for Conestoga Capital Advisors, LLC
• December 31, 2023 (date) — the date of the event requiring the filing
• January 5, 2024 (date) — the filing date of the SC 13G/A

Forward-Looking Statements

• Conestoga Capital Advisors, LLC will likely maintain a significant, passive stake in LeMaitre Vascular, Inc. (Conestoga Capital Advisors, LLC) — high confidence, target: Next 12-24 months
• LeMaitre Vascular, Inc. will continue to be viewed favorably by institutional investors due to existing large holdings. (LeMaitre Vascular, Inc.) — medium confidence, target: Next 6-12 months

FAQ

Key Financial Figures

• $0.01 — , Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securitie

Filing Documents

• lmata7_10524.htm (SC 13G/A) — 32KB
• 0001085146-24-000032.txt ( ) — 33KB

(a)

ITEM 1(a). NAME OF ISSUER: LeMaitre Vascular, Inc.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 63 Second Avenue Burlington, MA 01803 USA

(a)

ITEM 2(a). NAME OF PERSON FILING: Conestoga Capital Advisors, LLC Conestoga Small Cap Fund

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 550 E. Swedesford Rd.Ste 120 Wayne, Pa 19807

(c)

ITEM 2(c). CITIZENSHIP: Delaware Delaware

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.01 Par Value

(e)

ITEM 2(e). CUSIP NUMBER: 525558201 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [X] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: Conestoga Capital Advisors 2,061,262 Conestoga Small Cap Fund 1,365,296 (b) Percent of class: Conestoga Capital Advisors 9.26% Conestoga Small Cap Fund 6.13% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Conestoga Capital Advisors 1,927,971 Conestoga Small Cap Fund 1,365,296 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or direct the disposition of: Conestoga Capital Advisors 2,061,262 Conestoga Small Cap Fund 1,365,296 (iv) shared power to dispose or to direct the disposition of: 0 ITEM 5

View Full Filing

View this SC 13G/A filing on SEC EDGAR